Search Thermo Fisher Scientific
The Ion Torrent portfolio of B cell receptor (BCR) assays targets the immunoglobulin heavy (IGH) chain for next-generation sequencing (NGS). Fast and affordable B cell repertoire analysis is achieved with little DNA or RNA input, using the sequencing accuracy and sensitivity of the Ion GeneStudio S5 series systems.
The complete Ion Torrent sample to analysis workflow enables deeper insights through targeted sequencing.
The Ion Torrent Oncomine BCR IGH LR Assay uses the long-read sequencing capabilities of Ion Torrent technology to interrogate all complementarity determining regions (CDR1, CDR2, and CDR3) of the BCR IGH chain using low RNA sample input.
The Ion Torrent Oncomine BCR IGH-SR Assay allows you to interrogate the CDR3 region of the BCR IGH chain from human samples using either DNA or RNA as input. Targeting the diverse CDR3 region for B cells enables deeper insights in studying vaccine response, learning more about the cancer immunity cycle and research for evaluating measurable residual disease (MRD).
Transform your mouse model studies with targeted sequencing of the CDR3 region of the BCR IGH. Using either DNA or RNA sample input, the accuracy and sensitivity of the panel paired with an Ion GeneStudio S5 system enables a complete workflow that allows you to explore your data in as little as two days.
From sample to insights in as little as 48 hours.
Adopting NGS in your lab is now simpler than ever before. The Ion GeneStudio S5 series next-generation sequencing systems enable the simplest targeted sequencing workflow for your lab with superior speed and affordability. Focus your research efforts on applications that have the potential to be impactful. These NGS systems have a modular build, so your lab has the flexibility to do multiple targeted sequencing applications on a single system.
For Research Use Only. Not for use in diagnostic procedures.